1st Quarter - Report

CVS HEALTH (AND SUBSIDIARIES) for CVS HEALTH (AND SUBSIDIARIES)

Firm
Client
Income
—
Expenses
$1,460,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Pharmacy PHA

Issues related to prescription drug abuse, preferred pharmacy networks, pharmacist provider status, 340B, drug pricing and drug supply chain safety & Tricare. Issues related to biosimilars, FDA repackaging and drug disposal. HR 1600 :A bill to amend title XXVII of the Public Health Service Act to limit co-payment, coinsurance, or other cost-sharing requirements applicable to prescription drugs in a specialty drug tier to the dollar amount (or its equivalent) of such requirements applicable to prescription drugs in a non-preferred brand drug tier, and for other purposes. HR 592 - Pharmacy and Medically Underserved Areas Enhancement Act S 314 - Pharmacy and Medically Underserved Areas Enhancement Act HR 244 - MAC Transparency Act S 776 - Medication Therapy Management Empowerment Act of 2015 HR 471 - Ensuring Patient Access and Effective Drug Enforcement Act of 2015 S 483 - Ensuring Patient Access and Effective Drug Enforcement Act of 2015 HR 1735-National Defense Authorization Act for Fiscal Year 2016 HR 6-Stopping Medication Abuse and Protecting Seniors Act of 2015 S 1913-Stopping Medication Abuse and Protecting Seniors Act of 2015 HR 1725-National All Schedules Prescription Electronic Reporting Reauthorization Act of 2015 S 480-National All Schedules Prescription Electronic Reporting Reauthorization Act of 2015

LobbyistCovered position, as disclosed
ELIZABETH BROOKS New —
BRIAN FILES —
BILLY RAINES —
MARISSA SCHLAIFER —
MELISSA SCHULMAN —
ANN WALKER —

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS)

Bills named: H.R. 244 (114th), H.R. 592 (114th), H.R. 6 (114th), H.R. 1600 (114th), H.R. 1735 (114th), H.R. 471 (114th), H.R. 1725 (114th)

Health Issues HCR

Issues related to smoking cessation, Medicare Part D, contraceptive coverage and anti-PBM legislation. Other issues include health care delivery system reforms including telehealth, chronic care, Innovation Initiative & health IT, cost containment, medication adherence, restrictions on PBM cost saving tools like mail order, generics and restrictions on PBM audit practices. HR 793 - Ensuring Seniors Access to Local Pharmacies Act HR 2570-Strengthening Medicare Advantage through Innovation and Transparency for Seniors of 2015 HR 605-Medicare Home Infusion Site of Care Act S 275-Medicare Home Infusion Site of Care Act HR 2029-Consolidated Appropriations Act of 2016 S 2141-Transparent Ratings on Usability & Security to Transform Information Technology

LobbyistCovered position, as disclosed
ELIZABETH BROOKS New —
BRIAN FILES —
BILLY RAINES —
MARISSA SCHLAIFER —
MELISSA SCHULMAN —
ANN WALKER —

Contacted: SENATE; Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES

Bills named: H.R. 793 (114th), H.R. 2029 (114th), H.R. 605 (114th), H.R. 2570 (114th)

Medicare/Medicaid MMM

Medicare/Medicaid-Issues related to plan design, reimbursement, audit and cost savings proposals. Issues related to Part D Prescriber enrollment. HR 793 - Ensuring Seniors Access to Local Pharmacies Act

LobbyistCovered position, as disclosed
ELIZABETH BROOKS New —
MARISSA SCHLAIFER —
ANN WALKER —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Centers For Medicare and Medicaid Services (CMS)

Bills named: H.R. 793 (114th)

Taxation/Internal Revenue Code TAX

Issues related to restructuring of corporate tax rates. HR 3763-Surface Transportation Reauthorization & Reform Act of 2015

LobbyistCovered position, as disclosed
BILLY RAINES —
MELISSA SCHULMAN —
ANN WALKER —

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS)

Bills named: H.R. 3763 (114th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.